Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
المؤلفون الرئيسيون: | Nölting, S, Grossman, AB |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2012
|
مواد مشابهة
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
حسب: Korevaar, T, وآخرون
منشور في: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
حسب: Korevaar, T, وآخرون
منشور في: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
حسب: Nölting, S, وآخرون
منشور في: (2019) -
Pheochromocytomas and secreting paragangliomas
حسب: Gimenez-Roqueplo Anne-Paule, وآخرون
منشور في: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
حسب: Kaltsas, G, وآخرون
منشور في: (2003)